For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Amderma Pharmaceuticals, LLC

USPTO Granted Patents = 26

% Expired Patents = 100.0

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 150

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Pedro Cuevas Sànchez (14 out of 16 patents)

Guillermo Gimenez Gallego (13 out of 19 patents)

Serafin Valverde Lopez (13 out of 17 patents)

4. Rosa Maria Lozano Puerto (13 out of 17 patents)

5. Javier Angulo Frutos (12 out of 16 patents)

6. Antonio Romero Garrido (12 out of 17 patents)

7. Inigo Saenz De Tejada Gorman (11 out of 11 patents)

8. Pedro Cuevas Sánchez (6 out of 9 patents)

9. Unni Santhosh (5 out of 5 patents)

10. Annadurai Marimuthu Senthilkumar (5 out of 5 patents)

11. Bodireddy Mohan Reddy (5 out of 5 patents)

12. Rajendran Kamala (5 out of 5 patents)

13. Mahender Rao Siripragada (5 out of 5 patents)

14. Inigo Saenz De Tejada Morgan (2 out of 5 patents)

15. Arturo Angel (1 out of 28 patents)

Core Competencies:

2,5-Dihydroxybenzenesulfonic Acid

Skin Cancer

Dermatitis

Rosacea

Glioma

Psoriasis

Skin Photoaging

Actinic Keratosis

Angiodependent Diseases

26 patents: Sort by Forward Citations

1. 10632085 - Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts (2020-04-28),

2. 10441530 - Skin penetration enhancing systems for polar drugs (2019-10-15),

3. 10434076 - Use of 2,5-dihydroxybenzene derivatives for treating dermatitis (2019-10-08),

4. 10278941 - Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma (2019-05-07),

5. 10278940 - Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer (2019-05-07),

6. 10052294 - Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts (2018-08-21),

7. 9801838 - Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts (2017-10-31),

8. 9610256 - Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer (2017-04-04),

9. 9597303 - Use of 2,5-dihydroxybenzene derivatives for treating dermatitis (2017-03-21),

10. 9592216 - Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea (2017-03-14),

11. 9511044 - Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer (2016-12-06),

12. 9301931 - Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis (2016-04-05),

13. 9227928 - Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts (2016-01-05),

14. 9192592 - Use of 2,5-dihydroxybenzene derivatives for treating dermatitis (2015-11-24),

15. 9018195 - Use of 2,5-dihydroxybenzene sulfonic acid compounds for treating skin photoaging (2015-04-28),

Amderma Pharmaceuticals, LLC is a biopharmaceutical company based in Bridgewater, NJ, focused on developing innovative therapies for dermatological conditions. The organization specializes in advanced drug formulations and delivery systems aimed at improving patient outcomes in skin health. With a commitment to research and development, Amderma leverages cutting-edge technology to address unmet medical needs in the dermatology sector, contributing to the advancement of effective treatments for various skin disorders.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

26 Patents

#12 in Bridgewater, NJ

#502 in New Jersey

#12,843 in US

#24,758 in the World

Bridgewater, NJ, United States of America

Amderma Pharmaceuticals, LLC

Forward Citations = 150

19 inventors:

Pedro Cuevas Sànchez (14 out of 16 patents)

Guillermo Gimenez Gallego (13 out of 19 patents)

Serafin Valverde Lopez (13 out of 17 patents)

4. Rosa Maria Lozano Puerto (13 out of 17 patents)

5. Javier Angulo Frutos (12 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…